Claritev Stock
Claritev Corporation
Company data
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Country
- United States
- CEO
- Travis S. Dalton
- Employees
- 3,000
- Market cap
- $375 M
- IPO
- 03/04/2020
Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical…
Claritev stock: price history
1D
-7.3%
1W
-10.3%
1M
-34.1%
6M
+7.4%
YTD
-48.3%
1Y
-60.9%
2Y
–
5Y
–
10Y
–
Next earnings date
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~98% stronger price swings than usual
Claritev stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 18/09/2026.
Business model & megatrends
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
2 more assignments (Enabler/Second row) Pro-only.
Claritev Corporation is a specialized provider of data analytics and technology services in US healthcare. The company focuses on cost management, payment optimization, and revenue integrity assurance for insurers and other healthcare sector stakeholders. Through advanced algorithms and predictive analytics, the company identifies billing errors, supports reimbursement negotiations, and optimizes rate structures. A key component is the management of provider networks to ensure discounted rates, as well as the processing of B2B payments in healthcare. The offering encompasses both descriptive and prescriptive analytics to reduce medical costs and support decision-making processes in the insurance industry.
- Revenue model
- Transactional
- Recurring revenue
- High
- Pricing power
- Strong
- Moat
- Wide
- Moat type
- Switching costs
- Capital intensity
- Low
- Customer concentration
- Unknown
Ask the agents about Claritev
Analyst assessment of Claritev
PRICE TARGET LOW
US$40.00
CONSENSUS
US$52.00
MEDIAN
US$43.00
PRICE TARGET HIGH
US$73.00
0
STRONG BUY
5
BUY
1
HOLD
0
SELL
0
STRONG SELL
6
TOTAL · Buy
As of: 21/08/2026
Claritev stock metrics
P/E
-1.3
P/B
-1.27
EV/EBITDA
9.52
RETURN ON EQUITY
20.1%
NET MARGIN
-23.0%
DEBT/EQUITY
-15.69
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
40.8%
FLOAT SHARES
6,912,023
AVG. DAILY VOLUME (30D)
167,999
Insider transactions (SEC)
Misencik Tiffani
Misencik Tiffani
Garis Douglas Michael
Garis Douglas Michael
Letham Thomas Benjamin
Attention
Price since yesterday: -7.3%
Search (Google Trends)
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Claritev stock
What does Claritev do?
Claritev Corporation is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in United States.
The CEO is Travis S. Dalton, the company employs around 3,000 people.
The IPO was on 03/04/2020; the stock trades on NYSE under the ticker CTEV.
What do analysts say about Claritev stock?
6 analysts rate the stock, the consensus is Buy (as of 21/08/2026).
The average price target is US$52.00, ranging from US$40.00 to US$73.00, with a median of US$43.00.
This is an external assessment, not a statement by Market Jury.
When does Claritev report next?
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly 98% stronger than usual.
Does Claritev pay a dividend?
No, Claritev currently does not pay a dividend.
Which stocks are comparable to Claritev?
Comparable stocks include Hinge Health, HealthEquity, Heartflow, Omada Health, Teladoc Health, Evolent Health, SOPHiA GENETICS and Optima Health.
How can I get Claritev stock analyzed?
Clicking "Analyze stock" lets five strategies assess Claritev against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.